Retour
Fourchette du Jour
116,80 €
123,94 €
Fourchette 52 Semaines
18,23 €
151,18 €
Volume
259 922
Moyenne 50J / 200J
103,28 €
/
71,39 €
Clôture Précédente
116,23 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -81,7 | 0,3 |
| P/B | 22,8 | 3,0 |
| ROE % | -59,4 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
203,92 €
+69.4%
Low: 143,00 €
High: 255,00 €
BPA Prévisionnel
-3,88 €
CA Est.
26 667,0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
7,28 €
7,28 € – 7,28 €
|
307,96M | 4 |
| FY2028 |
-0,74 €
-7,04 € – 11,06 €
|
126,32M | 10 |
| FY2027 |
-4,99 €
-9,33 € – -2,66 €
|
24,88M | 11 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-11 | -0,85 € | -1,03 € | -21,2% |
| 2025-08-14 | -0,78 € | -0,86 € | -10,3% |
| 2025-05-15 | -3,40 € | -0,74 € | +78,2% |
| 2025-03-31 | -0,39 € | 4,00 € | +1125,6% |
| 2024-11-13 | -0,55 € | -2,19 € | -301,8% |
| 2024-08-14 | -2,40 € | -2,76 € | -15,0% |
| 2024-05-16 | -4,80 € | -2,00 € | +58,3% |
| 2024-03-30 | -9,60 € | -3,71 € | +61,4% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Points Clés
Earnings declined -193,27% over the past year
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -10,84M
PEG of 0,01 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-193,27%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-59,37%
ROIC-16,89%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,00
Current Ratio7,33
Interest Coverage-3,27
Valorisation
P/E Ratio
-81,74
Forward P/EN/A
P/B Ratio22,76
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -193,27% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -17,43M |
| ROE | -59,37% | ROA | -19,76% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -10,84M |
| ROIC | -16,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 7,33 |
| Interest Coverage | -3,27 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -81,74 | Forward P/E | N/A |
| P/B Ratio | 22,76 | P/S Ratio | N/A |
| PEG Ratio | 0,01 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 251548,13 |
| Forward P/S | 53440,89 | Fwd Earnings Yield | N/A |
| FCF Yield | -0,76% | ||
| Market Cap | 1,43B | Enterprise Value | 1,34B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 25,90M | 31,42M |
| Net Income | -17,43M | 18,69M | -33,28M | -45,74M |
| EPS (Diluted) | -7,83 | 14,74 | -29,61 | -56,69 |
| Gross Profit | 0,0 | 0,0 | 23,12M | 29,05M |
| Operating Income | -14,10M | -11,87M | -43,47M | -51,83M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 88,23M | 7,55M | 16,52M | 153,56M | 105,01M |
| Total Liabilities | 25,63M | 11,43M | 39,70M | 102,81M | 73,98M |
| Shareholders' Equity | 62,61M | -3,88M | -23,17M | 50,76M | 31,03M |
| Total Debt | 0,0 | 0,0 | 0,0 | 14,89M | 16,96M |
| Cash & Equivalents | 83,60M | 7,35M | 16,05M | 117,76M | 70,44M |
| Current Assets | 88,23M | 7,55M | 16,52M | 127,63M | 75,72M |
| Current Liabilities | 12,04M | 2,36M | 5,78M | 50,56M | 22,15M |